The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
about
An Endogenous Electron Spin Resonance (ESR) signal discriminates nevi from melanomas in human specimens: a step forward in its diagnostic application.Identification of serum regression signs in infantile hemangioma.Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.Stabilization of Sur8 via PKCα/δ degradation promotes transformation and migration of colorectal cancer cells.
P2860
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
@en
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
@nl
type
label
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
@en
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
@nl
prefLabel
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
@en
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.
@en
P2093
Alberto Parazzoli
Antonio Facchiano
Daniela D'Arcangelo
Debora Faraone
Francesco De Marchis
Gabriele Toietta
Maria S Aguzzi
Maurizio C Capogrossi
Paolo Colombo
P2860
P304
P356
10.1038/MT.2010.211
P577
2010-10-05T00:00:00Z